Barrett’s ESophagus Trial 3 (BEST3): Cluster randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/04/201931/03/2020

    Collaborative partners

    Funding

    • CRUK Cancer Research UK: £184,639.00
    • CRUK Cancer Research UK: £16,905.00